Ramm Pharma (TSE:RAMM) has released an update.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Ramm Pharma Corp. has announced that the Ontario Superior Court of Justice has dismissed both the CAD 3,139,931.30 claim against them and their CAD 14,220,000 counterclaim in a legal dispute with Sergio Martines and Naturale Science Inc. The court did award a minor sum for unpaid expenses to Martines. Ramm continues its operations in cannabinoid pharmacology with a diversified portfolio in various international markets.
For further insights into TSE:RAMM stock, check out TipRanks’ Stock Analysis page.